- call +1-201-465-4211
- email sales@mrinsights.biz
Serum biomarkers are proteins generally detected in urine, blood, and other bodily fluids produced by malignant cells or in reaction to presence/absence of malignant cells. Preferably, biomarkers should have at least one or more than one of the following properties: prompt detection of cancer within high risk population, diagnosis of specific type of cancer, prediction in its growth, screen its treatment response, and detect early recurrence.
Scope of the Report:
The global serum cancer biomarkers market is projected to grow at a rapid pace in the next few years. Key drivers of the market are increase in the number of people suffering from different types of cancer and rise in the geriatric population. Increase in the cancer-afflicted population is anticipated to be another key driver of the market.
The worldwide market for Serum Cancer Biomarkers is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Serum Cancer Biomarkers in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Roche
Pfizer
Novartis
Abbott
BD
Merck
Eli Lilly
Agilent Technologies
Boehringer Ingelheim
AstraZeneca
Bristol-Myers Squibb
Novo Nordisk
Allergan
Gilead
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Hepatocellular Carcinoma Serum Biomarkers
Lung Cancer Serum Biomarkers
Pancreatic & Biliary Tract Cancer Serum Biomarkers
Breast Cancer Serum Biomarkers
Glioblastoma Serum Biomarkers
Others
Market Segment by Applications, can be divided into
Hospitals
Academic & Research Institutes
Ambulatory Surgical Centers
Others
There are 15 Chapters to deeply display the global Serum Cancer Biomarkers market.
Chapter 1, to describe Serum Cancer Biomarkers Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Serum Cancer Biomarkers, with sales, revenue, and price of Serum Cancer Biomarkers, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Serum Cancer Biomarkers, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Serum Cancer Biomarkers market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Serum Cancer Biomarkers sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Serum Cancer Biomarkers Introduction
1.2 Market Analysis by Type
1.2.1 Hepatocellular Carcinoma Serum Biomarkers
1.2.2 Lung Cancer Serum Biomarkers
1.2.3 Pancreatic & Biliary Tract Cancer Serum Biomarkers
1.2.4 Breast Cancer Serum Biomarkers
1.2.5 Glioblastoma Serum Biomarkers
1.2.6 Others
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Academic & Research Institutes
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Serum Cancer Biomarkers Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Serum Cancer Biomarkers Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Serum Cancer Biomarkers Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Abbott
2.4.1 Business Overview
2.4.2 Serum Cancer Biomarkers Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Abbott Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 BD
2.5.1 Business Overview
2.5.2 Serum Cancer Biomarkers Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 BD Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Merck
2.6.1 Business Overview
2.6.2 Serum Cancer Biomarkers Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Merck Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Eli Lilly
2.7.1 Business Overview
2.7.2 Serum Cancer Biomarkers Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Eli Lilly Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Agilent Technologies
2.8.1 Business Overview
2.8.2 Serum Cancer Biomarkers Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Agilent Technologies Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Boehringer Ingelheim
2.9.1 Business Overview
2.9.2 Serum Cancer Biomarkers Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Boehringer Ingelheim Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 AstraZeneca
2.10.1 Business Overview
2.10.2 Serum Cancer Biomarkers Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 AstraZeneca Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Bristol-Myers Squibb
2.11.1 Business Overview
2.11.2 Serum Cancer Biomarkers Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Bristol-Myers Squibb Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Novo Nordisk
2.12.1 Business Overview
2.12.2 Serum Cancer Biomarkers Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Novo Nordisk Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Allergan
2.13.1 Business Overview
2.13.2 Serum Cancer Biomarkers Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Allergan Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Gilead
2.14.1 Business Overview
2.14.2 Serum Cancer Biomarkers Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Gilead Serum Cancer Biomarkers Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Serum Cancer Biomarkers Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Serum Cancer Biomarkers Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Serum Cancer Biomarkers Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Serum Cancer Biomarkers Manufacturer Market Share in 2017
3.3.2 Top 6 Serum Cancer Biomarkers Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Serum Cancer Biomarkers Market Analysis by Regions
4.1 Global Serum Cancer Biomarkers Sales, Revenue and Market Share by Regions
4.1.1 Global Serum Cancer Biomarkers Sales and Market Share by Regions (2013-2018)
4.1.2 Global Serum Cancer Biomarkers Revenue and Market Share by Regions (2013-2018)
4.2 North America Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
4.3 Europe Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
4.5 South America Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
5 North America Serum Cancer Biomarkers by Countries
5.1 North America Serum Cancer Biomarkers Sales, Revenue and Market Share by Countries
5.1.1 North America Serum Cancer Biomarkers Sales and Market Share by Countries (2013-2018)
5.1.2 North America Serum Cancer Biomarkers Revenue and Market Share by Countries (2013-2018)
5.2 United States Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
5.3 Canada Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
5.4 Mexico Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
6 Europe Serum Cancer Biomarkers by Countries
6.1 Europe Serum Cancer Biomarkers Sales, Revenue and Market Share by Countries
6.1.1 Europe Serum Cancer Biomarkers Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Serum Cancer Biomarkers Revenue and Market Share by Countries (2013-2018)
6.2 Germany Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
6.3 UK Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
6.4 France Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
6.5 Russia Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
6.6 Italy Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
7 Asia-Pacific Serum Cancer Biomarkers by Countries
7.1 Asia-Pacific Serum Cancer Biomarkers Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Serum Cancer Biomarkers Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Serum Cancer Biomarkers Revenue and Market Share by Countries (2013-2018)
7.2 China Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
7.3 Japan Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
7.4 Korea Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
7.5 India Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
8 South America Serum Cancer Biomarkers by Countries
8.1 South America Serum Cancer Biomarkers Sales, Revenue and Market Share by Countries
8.1.1 South America Serum Cancer Biomarkers Sales and Market Share by Countries (2013-2018)
8.1.2 South America Serum Cancer Biomarkers Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
8.3 Argentina Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
8.4 Colombia Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
9 Middle East and Africa Serum Cancer Biomarkers by Countries
9.1 Middle East and Africa Serum Cancer Biomarkers Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Serum Cancer Biomarkers Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Serum Cancer Biomarkers Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
9.3 UAE Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
9.4 Egypt Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
9.5 Nigeria Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
9.6 South Africa Serum Cancer Biomarkers Sales and Growth Rate (2013-2018)
10 Global Serum Cancer Biomarkers Market Segment by Type
10.1 Global Serum Cancer Biomarkers Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Serum Cancer Biomarkers Sales and Market Share by Type (2013-2018)
10.1.2 Global Serum Cancer Biomarkers Revenue and Market Share by Type (2013-2018)
10.2 Hepatocellular Carcinoma Serum Biomarkers Sales Growth and Price
10.2.1 Global Hepatocellular Carcinoma Serum Biomarkers Sales Growth (2013-2018)
10.2.2 Global Hepatocellular Carcinoma Serum Biomarkers Price (2013-2018)
10.3 Lung Cancer Serum Biomarkers Sales Growth and Price
10.3.1 Global Lung Cancer Serum Biomarkers Sales Growth (2013-2018)
10.3.2 Global Lung Cancer Serum Biomarkers Price (2013-2018)
10.4 Pancreatic & Biliary Tract Cancer Serum Biomarkers Sales Growth and Price
10.4.1 Global Pancreatic & Biliary Tract Cancer Serum Biomarkers Sales Growth (2013-2018)
10.4.2 Global Pancreatic & Biliary Tract Cancer Serum Biomarkers Price (2013-2018)
10.5 Breast Cancer Serum Biomarkers Sales Growth and Price
10.5.1 Global Breast Cancer Serum Biomarkers Sales Growth (2013-2018)
10.5.2 Global Breast Cancer Serum Biomarkers Price (2013-2018)
10.6 Glioblastoma Serum Biomarkers Sales Growth and Price
10.6.1 Global Glioblastoma Serum Biomarkers Sales Growth (2013-2018)
10.6.2 Global Glioblastoma Serum Biomarkers Price (2013-2018)
10.7 Others Sales Growth and Price
10.7.1 Global Others Sales Growth (2013-2018)
10.7.2 Global Others Price (2013-2018)
11 Global Serum Cancer Biomarkers Market Segment by Application
11.1 Global Serum Cancer Biomarkers Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Academic & Research Institutes Sales Growth (2013-2018)
11.4 Ambulatory Surgical Centers Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Serum Cancer Biomarkers Market Forecast (2018-2023)
12.1 Global Serum Cancer Biomarkers Sales, Revenue and Growth Rate (2018-2023)
12.2 Serum Cancer Biomarkers Market Forecast by Regions (2018-2023)
12.2.1 North America Serum Cancer Biomarkers Market Forecast (2018-2023)
12.2.2 Europe Serum Cancer Biomarkers Market Forecast (2018-2023)
12.2.3 Asia-Pacific Serum Cancer Biomarkers Market Forecast (2018-2023)
12.2.4 South America Serum Cancer Biomarkers Market Forecast (2018-2023)
12.2.5 Middle East and Africa Serum Cancer Biomarkers Market Forecast (2018-2023)
12.3 Serum Cancer Biomarkers Market Forecast by Type (2018-2023)
12.3.1 Global Serum Cancer Biomarkers Sales Forecast by Type (2018-2023)
12.3.2 Global Serum Cancer Biomarkers Market Share Forecast by Type (2018-2023)
12.4 Serum Cancer Biomarkers Market Forecast by Application (2018-2023)
12.4.1 Global Serum Cancer Biomarkers Sales Forecast by Application (2018-2023)
12.4.2 Global Serum Cancer Biomarkers Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Serum Cancer Biomarkers Picture
Table Product Specifications of Serum Cancer Biomarkers
Figure Global Sales Market Share of Serum Cancer Biomarkers by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
